Triomics builds AI software for oncology practices to automate clinical trial matching, appointment prep, and chart summarization.
$22MSeries B
A $22M Series B for oncology workflow automation signals that VCs are betting on AI-as-glue for fragmented clinical systems—not just diagnosis. Triomics is likely using this to expand from trial matching into the full patient journey (EHR integration, insurance pre-auth, follow-up scheduling). If you're building in adjacent healthcare verticals (rheumatology, cardiology), watch whether they're hiring for horizontal platform plays or staying vertical-focused; that tells you if the TAM is really about oncology or about replacing the broken appointment/documentation layer everywhere.